Supernus Pharmaceuticals, Inc.
DE ˙ DB ˙ US8684591089
37,80 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:S49 / Supernus Pharmaceuticals, Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership1,944 shares
Latest Disclosed Value $ 100,485
Rockefeller Capital Management L.P. reports 129.79% increase in ownership of S49 / Supernus Pharmaceuticals, Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 1,944 shares of Supernus Pharmaceuticals, Inc. (DE:S49) valued at $83,981 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 846 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of 129.79% during the quarter. The current value of the position is $73,483 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,944 1,098 129.79 100 138.10 0.0002
2026-03-16 2025-12-31 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 846 660 354.84 42 425.00 0.0001
2026-02-14 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 846 660 42 0.0000
2025-11-14 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 186 186 9 0.0000
2023-05-17 2023-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -18 -100.00 0 0.0000
2023-03-06 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 18 0 0.00 0 0.0000
2022-11-02 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 18 -124 -87.32 0 -100.00
2022-08-12 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 142 59 71.08 4 100.00 0.0000
2022-05-13 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 83 -248 -74.92 2 -77.78 0.0000
2022-02-14 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 331 331 9 0.0000
2021-02-12 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -315 -100.00 0 -100.00
2020-11-13 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 315 64 25.50 6 0.00 0.0001
2020-08-12 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 251 -202 -44.59 6 -25.00 0.0001
2020-05-12 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 453 323 248.46 8 166.67 0.0001
2020-02-07 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 130 -1,163 -89.95 3 -91.67 0.0000
2019-11-12 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,293 -30 -2.27 36 -18.18 0.0005
2019-08-09 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,323 241 22.27 44 15.79 0.0006
2019-05-10 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,082 757 232.92 38 245.45 0.0005
2019-02-12 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 325 0 0.00 11 -31.25 0.0002
2018-11-02 2018-09-30 13F Supernus Pharmaceuticals Common 868459108 325 0 0.00 16 -15.79 0.0002
2018-07-31 2018-06-30 13F Supernus Pharmaceuticals Common 868459108 325 325 19 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.